Presenting signs and patient co-variables in Gaucher disease: outcome of the Gaucher Earlier Diagnosis Consensus (GED-C) Delphi initiative
- Autores
- Mehta, Atul; Kuter, David J.; Salek, Sam S.; Belmatoug, Nadia; Bembi, Bruno; Bright, Jeremy; vom Dahl, Stephan; Deodato, Federica; Di Rocco, Maja; Göker Alpan, Ozlem; Hughes, Derralynn A.; Lukina, Elena A.; Machaczka, Maciej; Mengel, Eugen; Nagral, Aabha; Nakamura, Kimitoshi; Narita, Aya; Oliveri, María Beatriz; Pastores, Gregory; Pérez-López, Jordi; Ramaswami, Uma; Schwartz, Ida V.; Szer, Jeff; Weinreb, Neal J.; Zimran, Ari
- Año de publicación
- 2019
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Background: Gaucher disease (GD) presents with a range of signs and symptoms. Physicians can fail to recognise the early stages of GD owing to a lack of disease awareness, which can lead to significant diagnostic delays and sometimes irreversible but avoidable morbidities. Aim: The Gaucher Earlier Diagnosis Consensus (GED-C) initiative aimed to identify signs and co-variables considered most indicative of early type 1 and type 3 GD, to help non-specialists identify ‘at-risk’ patients who may benefit from diagnostic testing. Methods: An anonymous, three-round Delphi consensus process was deployed among a global panel of 22 specialists in GD (median experience 17.5 years, collectively managing almost 3000 patients). The rounds entailed data gathering, then importance ranking and establishment of consensus, using 5-point Likert scales and scoring thresholds defined a priori. Results: For type 1 disease, seven major signs (splenomegaly, thrombocytopenia, bone-related manifestations, anaemia, hyperferritinaemia, hepatomegaly and gammopathy) and two major co-variables (family history of GD and Ashkenazi-Jewish ancestry) were identified. For type 3 disease, nine major signs (splenomegaly, oculomotor disturbances, thrombocytopenia, epilepsy, anaemia, hepatomegaly, bone pain, motor disturbances and kyphosis) and one major co-variable (family history of GD) were identified. Lack of disease awareness, overlooking mild early signs and failure to consider GD as a diagnostic differential were considered major barriers to early diagnosis. Conclusion: The signs and co-variables identified in the GED-C initiative as potentially indicative of early GD will help to guide non-specialists and raise their index of suspicion in identifying patients potentially suitable for diagnostic testing for GD.
Fil: Mehta, Atul. University of California at Los Angeles; Estados Unidos
Fil: Kuter, David J.. Harvard Medical School; Estados Unidos
Fil: Salek, Sam S.. University Of Hertfordshire; Reino Unido
Fil: Belmatoug, Nadia. University Hospital Paris Nord Val de Seine.Referral Center for Lysosomal Diseases; Francia
Fil: Bembi, Bruno. Academic Medical Centre Hospital of Udine; Italia
Fil: Bright, Jeremy. Oxford PharmaGenesis Ltd. Research Evaluation Unit; Reino Unido
Fil: vom Dahl, Stephan. Heinrich-Heine University; Alemania
Fil: Deodato, Federica. Bambino Gesù Children’s Hospital; Italia
Fil: Di Rocco, Maja. Istituto Giannina Gaslini; Italia
Fil: Göker Alpan, Ozlem. No especifíca;
Fil: Hughes, Derralynn A.. University of California at Los Angeles; Estados Unidos
Fil: Lukina, Elena A.. National Research Center for Hematology; Rusia
Fil: Machaczka, Maciej. University Of Rzeszów; Polonia. Karolinska University Hospital Huddinge; Suecia
Fil: Mengel, Eugen. Johannes Gutenberg Universitat Mainz; Alemania
Fil: Nagral, Aabha. Apollo Hospital; India
Fil: Nakamura, Kimitoshi. Kumamoto University; Japón
Fil: Narita, Aya. Tottori University. Faculty Of Medicine; Japón
Fil: Oliveri, María Beatriz. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Inmunología, Genética y Metabolismo. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Inmunología, Genética y Metabolismo; Argentina
Fil: Pastores, Gregory. The Mater Misericordiae University Hospital; Irlanda
Fil: Pérez-López, Jordi. Hospital Vall d’Hebron; España
Fil: Ramaswami, Uma. Universidade Federal do Rio Grande do Sul; Brasil
Fil: Schwartz, Ida V.. Universidade Federal do Rio Grande do Sul; Brasil
Fil: Szer, Jeff. The Royal Melbourne Hospital; Australia
Fil: Weinreb, Neal J.. University of Miami; Estados Unidos
Fil: Zimran, Ari. Shaare Zedek Medical Center; Israel. Hadassah Medical School; Israel - Materia
-
ALGORITHM
INBORN ERROR
LYSOSOMAL STORAGE DISEASE
METABOLISM
SPLENOMEGALY
THROMBOCYTOPENIA - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/116167
Ver los metadatos del registro completo
id |
CONICETDig_c918e3512463cf3814cc3456e1a59c7d |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/116167 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Presenting signs and patient co-variables in Gaucher disease: outcome of the Gaucher Earlier Diagnosis Consensus (GED-C) Delphi initiativeMehta, AtulKuter, David J.Salek, Sam S.Belmatoug, NadiaBembi, BrunoBright, Jeremyvom Dahl, StephanDeodato, FedericaDi Rocco, MajaGöker Alpan, OzlemHughes, Derralynn A.Lukina, Elena A.Machaczka, MaciejMengel, EugenNagral, AabhaNakamura, KimitoshiNarita, AyaOliveri, María BeatrizPastores, GregoryPérez-López, JordiRamaswami, UmaSchwartz, Ida V.Szer, JeffWeinreb, Neal J.Zimran, AriALGORITHMINBORN ERRORLYSOSOMAL STORAGE DISEASEMETABOLISMSPLENOMEGALYTHROMBOCYTOPENIAhttps://purl.org/becyt/ford/3.2https://purl.org/becyt/ford/3Background: Gaucher disease (GD) presents with a range of signs and symptoms. Physicians can fail to recognise the early stages of GD owing to a lack of disease awareness, which can lead to significant diagnostic delays and sometimes irreversible but avoidable morbidities. Aim: The Gaucher Earlier Diagnosis Consensus (GED-C) initiative aimed to identify signs and co-variables considered most indicative of early type 1 and type 3 GD, to help non-specialists identify ‘at-risk’ patients who may benefit from diagnostic testing. Methods: An anonymous, three-round Delphi consensus process was deployed among a global panel of 22 specialists in GD (median experience 17.5 years, collectively managing almost 3000 patients). The rounds entailed data gathering, then importance ranking and establishment of consensus, using 5-point Likert scales and scoring thresholds defined a priori. Results: For type 1 disease, seven major signs (splenomegaly, thrombocytopenia, bone-related manifestations, anaemia, hyperferritinaemia, hepatomegaly and gammopathy) and two major co-variables (family history of GD and Ashkenazi-Jewish ancestry) were identified. For type 3 disease, nine major signs (splenomegaly, oculomotor disturbances, thrombocytopenia, epilepsy, anaemia, hepatomegaly, bone pain, motor disturbances and kyphosis) and one major co-variable (family history of GD) were identified. Lack of disease awareness, overlooking mild early signs and failure to consider GD as a diagnostic differential were considered major barriers to early diagnosis. Conclusion: The signs and co-variables identified in the GED-C initiative as potentially indicative of early GD will help to guide non-specialists and raise their index of suspicion in identifying patients potentially suitable for diagnostic testing for GD.Fil: Mehta, Atul. University of California at Los Angeles; Estados UnidosFil: Kuter, David J.. Harvard Medical School; Estados UnidosFil: Salek, Sam S.. University Of Hertfordshire; Reino UnidoFil: Belmatoug, Nadia. University Hospital Paris Nord Val de Seine.Referral Center for Lysosomal Diseases; FranciaFil: Bembi, Bruno. Academic Medical Centre Hospital of Udine; ItaliaFil: Bright, Jeremy. Oxford PharmaGenesis Ltd. Research Evaluation Unit; Reino UnidoFil: vom Dahl, Stephan. Heinrich-Heine University; AlemaniaFil: Deodato, Federica. Bambino Gesù Children’s Hospital; ItaliaFil: Di Rocco, Maja. Istituto Giannina Gaslini; ItaliaFil: Göker Alpan, Ozlem. No especifíca;Fil: Hughes, Derralynn A.. University of California at Los Angeles; Estados UnidosFil: Lukina, Elena A.. National Research Center for Hematology; RusiaFil: Machaczka, Maciej. University Of Rzeszów; Polonia. Karolinska University Hospital Huddinge; SueciaFil: Mengel, Eugen. Johannes Gutenberg Universitat Mainz; AlemaniaFil: Nagral, Aabha. Apollo Hospital; IndiaFil: Nakamura, Kimitoshi. Kumamoto University; JapónFil: Narita, Aya. Tottori University. Faculty Of Medicine; JapónFil: Oliveri, María Beatriz. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Inmunología, Genética y Metabolismo. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Inmunología, Genética y Metabolismo; ArgentinaFil: Pastores, Gregory. The Mater Misericordiae University Hospital; IrlandaFil: Pérez-López, Jordi. Hospital Vall d’Hebron; EspañaFil: Ramaswami, Uma. Universidade Federal do Rio Grande do Sul; BrasilFil: Schwartz, Ida V.. Universidade Federal do Rio Grande do Sul; BrasilFil: Szer, Jeff. The Royal Melbourne Hospital; AustraliaFil: Weinreb, Neal J.. University of Miami; Estados UnidosFil: Zimran, Ari. Shaare Zedek Medical Center; Israel. Hadassah Medical School; IsraelWiley Blackwell Publishing, Inc2019-05info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/116167Mehta, Atul; Kuter, David J.; Salek, Sam S.; Belmatoug, Nadia; Bembi, Bruno; et al.; Presenting signs and patient co-variables in Gaucher disease: outcome of the Gaucher Earlier Diagnosis Consensus (GED-C) Delphi initiative; Wiley Blackwell Publishing, Inc; Internal Medicine Journal; 49; 5; 5-2019; 578-5911444-0903CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://onlinelibrary.wiley.com/doi/abs/10.1111/imj.14156info:eu-repo/semantics/altIdentifier/doi/10.1111/imj.14156info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-nd/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T09:35:06Zoai:ri.conicet.gov.ar:11336/116167instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 09:35:07.221CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Presenting signs and patient co-variables in Gaucher disease: outcome of the Gaucher Earlier Diagnosis Consensus (GED-C) Delphi initiative |
title |
Presenting signs and patient co-variables in Gaucher disease: outcome of the Gaucher Earlier Diagnosis Consensus (GED-C) Delphi initiative |
spellingShingle |
Presenting signs and patient co-variables in Gaucher disease: outcome of the Gaucher Earlier Diagnosis Consensus (GED-C) Delphi initiative Mehta, Atul ALGORITHM INBORN ERROR LYSOSOMAL STORAGE DISEASE METABOLISM SPLENOMEGALY THROMBOCYTOPENIA |
title_short |
Presenting signs and patient co-variables in Gaucher disease: outcome of the Gaucher Earlier Diagnosis Consensus (GED-C) Delphi initiative |
title_full |
Presenting signs and patient co-variables in Gaucher disease: outcome of the Gaucher Earlier Diagnosis Consensus (GED-C) Delphi initiative |
title_fullStr |
Presenting signs and patient co-variables in Gaucher disease: outcome of the Gaucher Earlier Diagnosis Consensus (GED-C) Delphi initiative |
title_full_unstemmed |
Presenting signs and patient co-variables in Gaucher disease: outcome of the Gaucher Earlier Diagnosis Consensus (GED-C) Delphi initiative |
title_sort |
Presenting signs and patient co-variables in Gaucher disease: outcome of the Gaucher Earlier Diagnosis Consensus (GED-C) Delphi initiative |
dc.creator.none.fl_str_mv |
Mehta, Atul Kuter, David J. Salek, Sam S. Belmatoug, Nadia Bembi, Bruno Bright, Jeremy vom Dahl, Stephan Deodato, Federica Di Rocco, Maja Göker Alpan, Ozlem Hughes, Derralynn A. Lukina, Elena A. Machaczka, Maciej Mengel, Eugen Nagral, Aabha Nakamura, Kimitoshi Narita, Aya Oliveri, María Beatriz Pastores, Gregory Pérez-López, Jordi Ramaswami, Uma Schwartz, Ida V. Szer, Jeff Weinreb, Neal J. Zimran, Ari |
author |
Mehta, Atul |
author_facet |
Mehta, Atul Kuter, David J. Salek, Sam S. Belmatoug, Nadia Bembi, Bruno Bright, Jeremy vom Dahl, Stephan Deodato, Federica Di Rocco, Maja Göker Alpan, Ozlem Hughes, Derralynn A. Lukina, Elena A. Machaczka, Maciej Mengel, Eugen Nagral, Aabha Nakamura, Kimitoshi Narita, Aya Oliveri, María Beatriz Pastores, Gregory Pérez-López, Jordi Ramaswami, Uma Schwartz, Ida V. Szer, Jeff Weinreb, Neal J. Zimran, Ari |
author_role |
author |
author2 |
Kuter, David J. Salek, Sam S. Belmatoug, Nadia Bembi, Bruno Bright, Jeremy vom Dahl, Stephan Deodato, Federica Di Rocco, Maja Göker Alpan, Ozlem Hughes, Derralynn A. Lukina, Elena A. Machaczka, Maciej Mengel, Eugen Nagral, Aabha Nakamura, Kimitoshi Narita, Aya Oliveri, María Beatriz Pastores, Gregory Pérez-López, Jordi Ramaswami, Uma Schwartz, Ida V. Szer, Jeff Weinreb, Neal J. Zimran, Ari |
author2_role |
author author author author author author author author author author author author author author author author author author author author author author author author |
dc.subject.none.fl_str_mv |
ALGORITHM INBORN ERROR LYSOSOMAL STORAGE DISEASE METABOLISM SPLENOMEGALY THROMBOCYTOPENIA |
topic |
ALGORITHM INBORN ERROR LYSOSOMAL STORAGE DISEASE METABOLISM SPLENOMEGALY THROMBOCYTOPENIA |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.2 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
Background: Gaucher disease (GD) presents with a range of signs and symptoms. Physicians can fail to recognise the early stages of GD owing to a lack of disease awareness, which can lead to significant diagnostic delays and sometimes irreversible but avoidable morbidities. Aim: The Gaucher Earlier Diagnosis Consensus (GED-C) initiative aimed to identify signs and co-variables considered most indicative of early type 1 and type 3 GD, to help non-specialists identify ‘at-risk’ patients who may benefit from diagnostic testing. Methods: An anonymous, three-round Delphi consensus process was deployed among a global panel of 22 specialists in GD (median experience 17.5 years, collectively managing almost 3000 patients). The rounds entailed data gathering, then importance ranking and establishment of consensus, using 5-point Likert scales and scoring thresholds defined a priori. Results: For type 1 disease, seven major signs (splenomegaly, thrombocytopenia, bone-related manifestations, anaemia, hyperferritinaemia, hepatomegaly and gammopathy) and two major co-variables (family history of GD and Ashkenazi-Jewish ancestry) were identified. For type 3 disease, nine major signs (splenomegaly, oculomotor disturbances, thrombocytopenia, epilepsy, anaemia, hepatomegaly, bone pain, motor disturbances and kyphosis) and one major co-variable (family history of GD) were identified. Lack of disease awareness, overlooking mild early signs and failure to consider GD as a diagnostic differential were considered major barriers to early diagnosis. Conclusion: The signs and co-variables identified in the GED-C initiative as potentially indicative of early GD will help to guide non-specialists and raise their index of suspicion in identifying patients potentially suitable for diagnostic testing for GD. Fil: Mehta, Atul. University of California at Los Angeles; Estados Unidos Fil: Kuter, David J.. Harvard Medical School; Estados Unidos Fil: Salek, Sam S.. University Of Hertfordshire; Reino Unido Fil: Belmatoug, Nadia. University Hospital Paris Nord Val de Seine.Referral Center for Lysosomal Diseases; Francia Fil: Bembi, Bruno. Academic Medical Centre Hospital of Udine; Italia Fil: Bright, Jeremy. Oxford PharmaGenesis Ltd. Research Evaluation Unit; Reino Unido Fil: vom Dahl, Stephan. Heinrich-Heine University; Alemania Fil: Deodato, Federica. Bambino Gesù Children’s Hospital; Italia Fil: Di Rocco, Maja. Istituto Giannina Gaslini; Italia Fil: Göker Alpan, Ozlem. No especifíca; Fil: Hughes, Derralynn A.. University of California at Los Angeles; Estados Unidos Fil: Lukina, Elena A.. National Research Center for Hematology; Rusia Fil: Machaczka, Maciej. University Of Rzeszów; Polonia. Karolinska University Hospital Huddinge; Suecia Fil: Mengel, Eugen. Johannes Gutenberg Universitat Mainz; Alemania Fil: Nagral, Aabha. Apollo Hospital; India Fil: Nakamura, Kimitoshi. Kumamoto University; Japón Fil: Narita, Aya. Tottori University. Faculty Of Medicine; Japón Fil: Oliveri, María Beatriz. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Inmunología, Genética y Metabolismo. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Inmunología, Genética y Metabolismo; Argentina Fil: Pastores, Gregory. The Mater Misericordiae University Hospital; Irlanda Fil: Pérez-López, Jordi. Hospital Vall d’Hebron; España Fil: Ramaswami, Uma. Universidade Federal do Rio Grande do Sul; Brasil Fil: Schwartz, Ida V.. Universidade Federal do Rio Grande do Sul; Brasil Fil: Szer, Jeff. The Royal Melbourne Hospital; Australia Fil: Weinreb, Neal J.. University of Miami; Estados Unidos Fil: Zimran, Ari. Shaare Zedek Medical Center; Israel. Hadassah Medical School; Israel |
description |
Background: Gaucher disease (GD) presents with a range of signs and symptoms. Physicians can fail to recognise the early stages of GD owing to a lack of disease awareness, which can lead to significant diagnostic delays and sometimes irreversible but avoidable morbidities. Aim: The Gaucher Earlier Diagnosis Consensus (GED-C) initiative aimed to identify signs and co-variables considered most indicative of early type 1 and type 3 GD, to help non-specialists identify ‘at-risk’ patients who may benefit from diagnostic testing. Methods: An anonymous, three-round Delphi consensus process was deployed among a global panel of 22 specialists in GD (median experience 17.5 years, collectively managing almost 3000 patients). The rounds entailed data gathering, then importance ranking and establishment of consensus, using 5-point Likert scales and scoring thresholds defined a priori. Results: For type 1 disease, seven major signs (splenomegaly, thrombocytopenia, bone-related manifestations, anaemia, hyperferritinaemia, hepatomegaly and gammopathy) and two major co-variables (family history of GD and Ashkenazi-Jewish ancestry) were identified. For type 3 disease, nine major signs (splenomegaly, oculomotor disturbances, thrombocytopenia, epilepsy, anaemia, hepatomegaly, bone pain, motor disturbances and kyphosis) and one major co-variable (family history of GD) were identified. Lack of disease awareness, overlooking mild early signs and failure to consider GD as a diagnostic differential were considered major barriers to early diagnosis. Conclusion: The signs and co-variables identified in the GED-C initiative as potentially indicative of early GD will help to guide non-specialists and raise their index of suspicion in identifying patients potentially suitable for diagnostic testing for GD. |
publishDate |
2019 |
dc.date.none.fl_str_mv |
2019-05 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/116167 Mehta, Atul; Kuter, David J.; Salek, Sam S.; Belmatoug, Nadia; Bembi, Bruno; et al.; Presenting signs and patient co-variables in Gaucher disease: outcome of the Gaucher Earlier Diagnosis Consensus (GED-C) Delphi initiative; Wiley Blackwell Publishing, Inc; Internal Medicine Journal; 49; 5; 5-2019; 578-591 1444-0903 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/116167 |
identifier_str_mv |
Mehta, Atul; Kuter, David J.; Salek, Sam S.; Belmatoug, Nadia; Bembi, Bruno; et al.; Presenting signs and patient co-variables in Gaucher disease: outcome of the Gaucher Earlier Diagnosis Consensus (GED-C) Delphi initiative; Wiley Blackwell Publishing, Inc; Internal Medicine Journal; 49; 5; 5-2019; 578-591 1444-0903 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://onlinelibrary.wiley.com/doi/abs/10.1111/imj.14156 info:eu-repo/semantics/altIdentifier/doi/10.1111/imj.14156 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-nd/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-nd/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Wiley Blackwell Publishing, Inc |
publisher.none.fl_str_mv |
Wiley Blackwell Publishing, Inc |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1844613091632873472 |
score |
13.070432 |